Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Mol Psychiatry ; 15(5): 535-47, 2010 May.
Artículo en Inglés | MEDLINE | ID: mdl-18521089

RESUMEN

Interferon (IFN)-alpha has been used to investigate pathways by which innate immune cytokines influence the brain and behavior. Accordingly, the impact of IFN-alpha on diurnal secretion of hypothalamic-pituitary-adrenal (HPA) axis hormones was assessed in 33 patients eligible for treatment with IFN-alpha plus ribavirin for hepatitis C. In addition, the relationship between IFN-alpha-induced HPA axis changes and proinflammatory cytokines and behavior was examined. Plasma ACTH and cortisol as well as tumor necrosis factor (TNF)-alpha, interleukin-6 and their soluble receptors, were measured hourly between 0900 and 2100 hours at baseline and following approximately 12 weeks of either no treatment (n=13) or treatment with IFN-alpha/ribavirin (n=20). Plasma IFN-alpha was also measured at each visit. Depression and fatigue were assessed using the Montgomery-Asberg depression rating scale and the multidimensional fatigue inventory. Compared to no treatment, IFN-alpha/ribavirin administration was associated with significant flattening of the diurnal ACTH and cortisol slope and increased evening plasma ACTH and cortisol concentrations. Flattening of the cortisol slope and increases in evening cortisol were correlated with increases in depression (r=0.38, P<0.05 and r=0.36, P<0.05, respectively) and fatigue (r=0.43, P<0.05 and r=0.49, P<0.01, respectively). No relationship was found between immune and HPA axis measures, although increases in plasma IFN-alpha, TNF-alpha and soluble TNF-alpha receptor2 were independently correlated with behavioral endpoints. These data indicate that chronic exposure to innate immune cytokines may contribute to the altered diurnal HPA axis activity and behavior found in medically ill individuals. However, given the lack of correlation between HPA axis and immune measures, the mechanism by which chronic cytokine exposure influences HPA axis function remains to be determined.


Asunto(s)
Antivirales/farmacología , Ritmo Circadiano/efectos de los fármacos , Citocinas/sangre , Hepatitis C/patología , Hepatitis C/fisiopatología , Sistema Hipotálamo-Hipofisario/efectos de los fármacos , Interferón-alfa/farmacología , Sistema Hipófiso-Suprarrenal/efectos de los fármacos , Hormona Adrenocorticotrópica/sangre , Adulto , Antivirales/uso terapéutico , Ritmo Circadiano/fisiología , Depresión/tratamiento farmacológico , Depresión/etiología , Ensayo de Inmunoadsorción Enzimática , Fatiga/tratamiento farmacológico , Fatiga/etiología , Femenino , Hepatitis C/tratamiento farmacológico , Humanos , Hidrocortisona/sangre , Interferón-alfa/efectos de los fármacos , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Ribavirina/farmacología , Ribavirina/uso terapéutico , Estadística como Asunto , Estadísticas no Paramétricas
2.
Biol Psychiatry ; 65(4): 296-303, 2009 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-18801471

RESUMEN

BACKGROUND: Interferon (IFN)-alpha has been used to study the effects of innate immune cytokines on the brain and behavior in humans. The degree to which peripheral administration of IFN-alpha accesses the brain and is associated with a central nervous system (CNS) inflammatory response is unknown. Moreover, the relationship among IFN-alpha-associated CNS inflammatory responses, neurotransmitter metabolism, and behavior has yet to be established. METHODS: Twenty-four patients with hepatitis C underwent lumbar puncture and blood sampling after approximately 12 weeks of either no treatment (n = 12) or treatment with pegylated IFN-alpha 2b (n = 12). Cerebrospinal fluid (CSF) and blood samples were analyzed for proinflammatory cytokines and their receptors as well as the chemokine, monocyte chemoattractant protein-1 (MCP-1), and IFN-alpha. Cerebrospinal fluid samples were additionally analyzed for monoamine metabolites and corticotropin releasing hormone. Depressive symptoms were assessed using the Montgomery Asberg Depression Rating Scale. RESULTS: Interferon-alpha was detected in the CSF of all IFN-alpha-treated patients and only one control subject. Despite no increases in plasma IL-6, IFN-alpha-treated patients exhibited significant elevations in CSF IL-6 and MCP-1, both of which were highly correlated with CSF IFN-alpha concentrations. Of the immunologic and neurotransmitter variables, log-transformed CSF concentrations of the serotonin metabolite, 5-hydroxyindoleacetic acid (5-HIAA), were the strongest predictor of depressive symptoms. Log-transformed CSF concentrations of IL-6, but not IFN-alpha or MCP-1, were negatively correlated with log-transformed CSF 5-HIAA (r(2) = -.25, p < .05). CONCLUSIONS: These data indicate that a peripherally administered cytokine can activate a CNS inflammatory response in humans that interacts with monoamine (serotonin) metabolism, which is associated with depression.


Asunto(s)
Monoaminas Biogénicas/fisiología , Sistema Nervioso Central/efectos de los fármacos , Sistema Nervioso Central/patología , Trastorno Depresivo/patología , Inflamación/patología , Interferón-alfa/farmacología , Vías Nerviosas/efectos de los fármacos , Vías Nerviosas/patología , Adulto , Antivirales/farmacología , Monoaminas Biogénicas/líquido cefalorraquídeo , Biomarcadores/análisis , Hormona Liberadora de Corticotropina/líquido cefalorraquídeo , Citocinas/líquido cefalorraquídeo , Trastorno Depresivo/líquido cefalorraquídeo , Femenino , Humanos , Inflamación/líquido cefalorraquídeo , Estudios Longitudinales , Masculino , Escalas de Valoración Psiquiátrica , Ribavirina/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA